drugset / Trial / NCT01092143

BI 671800 ED in Steroid-naive Asthmatic Patients

NCT01092143

Phase 2 Completed 389 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a 6 week study to investigate the effectiveness and safety of BI 671800 ED in patients with asthma who do not take inhaled corticosteroids.

Timeline

Start
2010-03-18
Primary completion
2011-03-26
Completion
2011-03-26

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 671800 Small molecule 50 mg Oral
Subject BI 671800 Small molecule 200 mg Oral
Subject BI 671800 Small molecule 400 mg Oral
Comparator Fluticasone propionate Other / unclassified Inhaled

Indications